Avanos Medical (AVNS) Competitors

Avanos Medical (NYSE:AVNS) and National Vision (NASDAQ:EYE) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Which has more risk & volatility, AVNS or EYE?

Avanos Medical has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Does the media refer more to AVNS or EYE?

In the previous week, National Vision had 7 more articles in the media than Avanos Medical. MarketBeat recorded 13 mentions for National Vision and 6 mentions for Avanos Medical. National Vision's average media sentiment score of 1.20 beat Avanos Medical's score of 0.76 indicating that National Vision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	5 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders have more ownership in AVNS or EYE?

95.2% of Avanos Medical shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by company insiders. Comparatively, 2.7% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is AVNS or EYE more profitable?

National Vision has a net margin of -1.40% compared to Avanos Medical's net margin of -55.80%. Avanos Medical's return on equity of 6.26% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-55.80%	6.26%	4.63%
National Vision	-1.40%	3.44%	1.40%

Do analysts prefer AVNS or EYE?

National Vision has a consensus target price of $24.18, suggesting a potential downside of 0.12%. Given National Vision's stronger consensus rating and higher probable upside, analysts plainly believe National Vision is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
National Vision	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Which has better earnings & valuation, AVNS or EYE?

National Vision has higher revenue and earnings than Avanos Medical. National Vision is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$687.80M	0.74	-$392.10M	-$8.37	-1.31
National Vision	$1.82B	1.05	-$28.50M	-$0.33	-73.36

Summary

National Vision beats Avanos Medical on 12 of the 16 factors compared between the two stocks.